PLCB4 upregulation is associated with unfavorable prognosis in pediatric acute myeloid leukemia

Shiwen Wu(First Hospital of Lanzhou University), Li Zhao(First Hospital of Lanzhou University), Dongqin Shen(First Hospital of Lanzhou University), Jianle Lu(Lanzhou University), Wei Zhang(First Hospital of Lanzhou University)
Oncology Letters
September 25, 2019
10.3892/ol.2019.10921
Cited by 13

Related Papers

Acute myeloid leukemia (<scp>AML)</scp>‐derived mesenchymal stem cells induce chemoresistance and epithelial–mesenchymal transition‐like program in <scp>AML</scp> through <scp>IL</scp>‐6/<scp>JAK2</scp>/<scp>STAT3</scp> signaling
|Cancer Science|2023|46
Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT/mTOR
|Anti-Cancer Drugs|2024|10
The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia
|Journal of Cancer Research and Clinical Oncology|2023|6
The FTO inhibitor Rhein is a promising option for the treatment of multidrug resistance AML
|Research Square|2024|0